Leadiant Biosciences, Inc. 2023-02-22 Health serious FDA
Health · FDA · Recall #FDA-D-0327-2023
Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL, 100 mg vial, Rx only,… Recall
Issued February 22, 2023 · Leadiant Biosciences, Inc.
In February 2023, Leadiant Biosciences, Inc. recalled the Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL, 100 mg vial, Rx only,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.
What you should do
- 1 Stop using Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL, 100 mg vial, Rx only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Leadiant Biosciences, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Leadiant Biosciences, Inc.
- Category
- Health
- Recall date
- February 22, 2023
- Units affected
- Not reported
- Sold at
- Nationwide USA
- Recall number
- FDA-D-0327-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Leadiant Biosciences, Inc. has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.